DRKS00029906RecruitingUnknown
utritional study on the importance of a probiotic multispecies product for the composition and diversity of the intestinal microbiome with simultaneous administration of antibiotics - OMNi-BiOTiC® 10
Institut AllergoSanPharmazeutische Produkte Forschungs- und Vertriebs GmbH0 sites500 target enrollmentStarted: March 20, 2023Last updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Enrollment
- 500
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized controlled study
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •According to medical assessment, necessary antibiotic therapy of a bacterial infectious disease (e.g. bronchopulmonary infections, urinary tract infections) by broad-spectrum antibiotics administered orally or intravenously (e.g. clindamycin, Cephalosporins, fluoroquinolones, macrolides, penicillins)
- •The possibility of using antibiotics within 24 hours with the consumption of Study medication to begin
- •Written consent after comprehensive information
- •No fundamental changes in dietary patterns during the Participation in studies
Exclusion Criteria
- •Antibiotic use within the last 4 weeks before the start of the study
- •Planned intestinal lavage (e.g. before colonoscopy)
- •Diarrhoeal disease within the last 4 weeks before the start of studies
- •Consumption of other probiotics within the last 4 weeks
- •Regular use of laxatives
- •Consumption of peristaltic inhibitors
- •Chronic diarrhoeal disease (e.g. chronic inflammatory bowel disease or Malassimilation)
- •Immunosuppression due to illness and/or medication
- •Patients with sepsis, current cancer or dialysis
- •Accompanying circumstances that lead to a consistent implementation of probiotics intake and the
- •Do not allow keeping a diary (e.g. dementia, ventilation, planned surgery)
Investigators
Similar Trials
Completed
Not Applicable
A study on the significance of probiotic treatment for type 2 diabetes patients with periodontal diseaseType2 diabetes mellitus and periodontal diseaseJPRN-UMIN000032553ational Hospital Organization Kagoshima Medical Center20
Unknown
Phase 4
Studying the role of probiotics for the treatment of early stage of cervical cancer in BangladeshCTRI/2021/07/034616BANBEIS Ministry of Education
Not yet recruiting
Not Applicable
Value of Immunomodulator drug(probiotics) in lung function of Bronchial Asthma subjectsCTRI/2021/03/032105Boopathi S
Completed
Not Applicable
Effect of probiotics following antibiotic therapyOral antibiotic therapyInfections and InfestationsISRCTN16359093Cultech Ltd78
Not yet recruiting
Not Applicable
Efficacy of probiotics combined with antibiotics in critically ill children with severe infectioCTRI/2012/07/002830ICMR Applied for180